vs
Aflac（AFL）与CLOVER HEALTH INVESTMENTS, CORP.（CLOV）财务数据对比。点击上方公司名可切换其他公司
Aflac的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的10.0倍（$4.9B vs $487.7M）。Aflac净利率更高（28.3% vs -10.1%，领先38.5%）。CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（44.7% vs -10.0%）。过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（18.6% vs -5.4%）
Aflac是美国知名保险企业，也是美国最大的补充保险提供商，成立于1955年，总部位于佐治亚州哥伦布市。公司在美国推出多类保险产品，其中薪资抵扣型保险服务知名度较高，参保人遭遇保障范围内的意外或疾病时可获现金赔付，目前已为全球超5000万用户提供财务保障。
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
AFL vs CLOV — 直观对比
营收规模更大
AFL
是对方的10.0倍
$487.7M
营收增速更快
CLOV
高出54.7%
-10.0%
净利率更高
AFL
高出38.5%
-10.1%
两年增速更快
CLOV
近两年复合增速
-5.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $4.9B | $487.7M |
| 净利润 | $1.4B | $-49.3M |
| 毛利率 | — | — |
| 营业利润率 | 32.3% | -10.1% |
| 净利率 | 28.3% | -10.1% |
| 营收同比 | -10.0% | 44.7% |
| 净利润同比 | -27.5% | -123.2% |
| 每股收益（稀释后） | $2.58 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AFLCLOV
| Q4 25 | $4.9B | $487.7M | ||
| Q3 25 | $4.7B | $496.6M | ||
| Q2 25 | $4.2B | $477.6M | ||
| Q1 25 | $3.4B | $462.3M | ||
| Q4 24 | $5.4B | $337.0M | ||
| Q3 24 | $2.9B | $331.0M | ||
| Q2 24 | $5.1B | $356.3M | ||
| Q1 24 | $5.4B | $346.9M |
净利润AFLCLOV
| Q4 25 | $1.4B | $-49.3M | ||
| Q3 25 | $1.6B | $-24.4M | ||
| Q2 25 | $599.0M | $-10.6M | ||
| Q1 25 | $29.0M | $-1.3M | ||
| Q4 24 | $1.9B | $-22.1M | ||
| Q3 24 | $-93.0M | $-9.2M | ||
| Q2 24 | $1.8B | $7.4M | ||
| Q1 24 | $1.9B | $-19.2M |
毛利率AFLCLOV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 30.3% | ||
| Q1 24 | — | 23.6% |
营业利润率AFLCLOV
| Q4 25 | 32.3% | -10.1% | ||
| Q3 25 | 42.1% | -4.9% | ||
| Q2 25 | 19.8% | -2.2% | ||
| Q1 25 | 4.3% | -0.3% | ||
| Q4 24 | 39.5% | -6.4% | ||
| Q3 24 | 3.1% | -2.7% | ||
| Q2 24 | 39.3% | 2.0% | ||
| Q1 24 | 39.9% | -6.5% |
净利率AFLCLOV
| Q4 25 | 28.3% | -10.1% | ||
| Q3 25 | 34.6% | -4.9% | ||
| Q2 25 | 14.4% | -2.2% | ||
| Q1 25 | 0.9% | -0.3% | ||
| Q4 24 | 35.2% | -6.6% | ||
| Q3 24 | -3.2% | -2.8% | ||
| Q2 24 | 34.2% | 2.1% | ||
| Q1 24 | 34.6% | -5.5% |
每股收益（稀释后）AFLCLOV
| Q4 25 | $2.58 | — | ||
| Q3 25 | $3.08 | — | ||
| Q2 25 | $1.11 | — | ||
| Q1 25 | $0.05 | — | ||
| Q4 24 | $3.45 | — | ||
| Q3 24 | $-0.17 | — | ||
| Q2 24 | $3.10 | — | ||
| Q1 24 | $3.25 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.2B | $78.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $29.5B | $308.7M |
| 总资产 | $116.5B | $541.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AFLCLOV
| Q4 25 | $6.2B | $78.3M | ||
| Q3 25 | $6.8B | — | ||
| Q2 25 | $7.0B | — | ||
| Q1 25 | $5.2B | — | ||
| Q4 24 | $6.2B | $194.5M | ||
| Q3 24 | $5.6B | $288.0M | ||
| Q2 24 | $6.1B | $254.8M | ||
| Q1 24 | $5.1B | $208.3M |
股东权益AFLCLOV
| Q4 25 | $29.5B | $308.7M | ||
| Q3 25 | $28.7B | $340.9M | ||
| Q2 25 | $27.2B | $344.2M | ||
| Q1 25 | $26.3B | $336.1M | ||
| Q4 24 | $26.1B | $341.1M | ||
| Q3 24 | $24.8B | $342.2M | ||
| Q2 24 | $26.0B | $324.9M | ||
| Q1 24 | $23.5B | $292.5M |
总资产AFLCLOV
| Q4 25 | $116.5B | $541.0M | ||
| Q3 25 | $122.3B | $559.7M | ||
| Q2 25 | $124.7B | $575.0M | ||
| Q1 25 | $120.3B | $583.7M | ||
| Q4 24 | $117.6B | $580.7M | ||
| Q3 24 | $128.4B | $653.0M | ||
| Q2 24 | $120.2B | $674.2M | ||
| Q1 24 | $124.7B | $671.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $315.0M | $-68.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-68.7M |
| 自由现金流率自由现金流/营收 | — | -14.1% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | 0.23× | — |
| 过去12个月自由现金流最近4个季度 | — | $-69.0M |
8季度趋势，按日历期对齐
经营现金流AFLCLOV
| Q4 25 | $315.0M | $-68.2M | ||
| Q3 25 | $1.3B | $12.1M | ||
| Q2 25 | $399.0M | $5.4M | ||
| Q1 25 | $589.0M | $-16.3M | ||
| Q4 24 | $333.0M | $-85.8M | ||
| Q3 24 | $1.3B | $50.0M | ||
| Q2 24 | $255.0M | $44.8M | ||
| Q1 24 | $849.0M | $25.9M |
自由现金流AFLCLOV
| Q4 25 | — | $-68.7M | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | — | $4.8M | ||
| Q1 25 | — | $-16.5M | ||
| Q4 24 | — | $-86.1M | ||
| Q3 24 | — | $49.6M | ||
| Q2 24 | — | $44.4M | ||
| Q1 24 | — | $25.5M |
自由现金流率AFLCLOV
| Q4 25 | — | -14.1% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | -3.6% | ||
| Q4 24 | — | -25.6% | ||
| Q3 24 | — | 15.0% | ||
| Q2 24 | — | 12.5% | ||
| Q1 24 | — | 7.3% |
资本支出强度AFLCLOV
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
现金转化率AFLCLOV
| Q4 25 | 0.23× | — | ||
| Q3 25 | 0.76× | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 20.31× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.15× | 6.04× | ||
| Q1 24 | 0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AFL
| Aflac Japan | $2.3B | 47% |
| Aflac US | $1.7B | 35% |
| Other | $862.0M | 18% |
CLOV
暂无分部数据
